Analysts at Barclays started coverage on shares of AMETEK (NYSE:AME - Get Free Report) in a research report issued on Wednesday,Benzinga reports. The brokerage set an "equal weight" rating and a $200.00 price target on the technology company's stock. Barclays's target price points to a potential upside of 6.73% from the stock's previous close.
A number of other research analysts also recently issued reports on the company. Royal Bank Of Canada upped their price target on AMETEK from $209.00 to $212.00 and gave the company an "outperform" rating in a report on Friday, August 1st. KeyCorp increased their target price on AMETEK from $195.00 to $205.00 and gave the company an "overweight" rating in a report on Friday, August 1st. DA Davidson increased their target price on AMETEK from $210.00 to $215.00 and gave the company a "buy" rating in a report on Friday, August 1st. Robert W. Baird increased their target price on AMETEK from $190.00 to $198.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Finally, Mizuho increased their target price on AMETEK from $212.00 to $225.00 and gave the company an "outperform" rating in a report on Friday, August 1st. Seven equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $205.00.
Read Our Latest Research Report on AMETEK
AMETEK Trading Down 0.7%
Shares of NYSE:AME opened at $187.38 on Wednesday. The company has a market cap of $43.28 billion, a P/E ratio of 30.17, a PEG ratio of 2.71 and a beta of 1.10. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.63 and a quick ratio of 1.04. AMETEK has a 1 year low of $145.02 and a 1 year high of $198.33. The stock's fifty day moving average price is $182.87 and its 200-day moving average price is $177.07.
AMETEK (NYSE:AME - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.69 by $0.09. The firm had revenue of $1.78 billion for the quarter, compared to the consensus estimate of $1.74 billion. AMETEK had a return on equity of 16.53% and a net margin of 20.60%.The company's quarterly revenue was up 2.5% on a year-over-year basis. During the same period in the prior year, the company posted $1.66 earnings per share. AMETEK has set its Q3 2025 guidance at 1.720-1.760 EPS. FY 2025 guidance at 7.060-7.200 EPS. Sell-side analysts expect that AMETEK will post 7.15 earnings per share for the current year.
Institutional Trading of AMETEK
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Darwin Wealth Management LLC purchased a new stake in AMETEK in the second quarter worth about $25,000. Bares Capital Management Inc. purchased a new stake in shares of AMETEK during the first quarter worth about $26,000. ST Germain D J Co. Inc. grew its position in shares of AMETEK by 628.6% during the second quarter. ST Germain D J Co. Inc. now owns 153 shares of the technology company's stock worth $28,000 after purchasing an additional 132 shares in the last quarter. NewSquare Capital LLC grew its position in shares of AMETEK by 129.7% during the second quarter. NewSquare Capital LLC now owns 170 shares of the technology company's stock worth $31,000 after purchasing an additional 96 shares in the last quarter. Finally, Olde Wealth Management LLC purchased a new stake in shares of AMETEK during the first quarter worth about $29,000. Hedge funds and other institutional investors own 87.43% of the company's stock.
AMETEK Company Profile
(
Get Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.